6 completed. 6 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 6 |
| Phase 3 | 1 | Completed 1 |
Follow Lymphatic Filariasis: new trials by email Literature Review of Lymphatic Filariasis trials Research Report on Lymphatic Filariasis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PK PD Study of IDA and Azithromycin for NTDs ( ComboNTDs ) Azithromycin, Albendazole, Ivermectin - Lymphatic Filariasis, Yaws | Phase 2 | Completed | Lihir Medical Centre | 42 | 2018-09-01 | 2019-02-28 |
| Repeat Ivermectin Mass Drug Administrations for Control of Malaria: a Pilot Safety and Efficacy Study Ivermectin, Albendazole - Malaria, Lymphatic Filariasis | Phase 2 / Phase 3 | Completed | Colorado State University | 2712 | 2015-06-01 | 2019-01-04 |
| Eval 3-Drug Therapy Diethylcarbamize, Albendazole and Ivermectin That Could Accelerate LF Elimination Outside of Africa Diethylcarbamazine, Albendazole, Ivermectin - Lymphatic Filariasis | Phase 2 | Completed | University Hospitals Cleveland Medical Center | 182 | 2014-05-01 | 2018-10-09 |
| Effect of Albendazole Dose on Treatment of Lymphatic Filariasis Albendazole, Diethylcarbamazine - Lymphatic Filariasis | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 40 | 2007-07-01 | 2015-08-31 |
| Effect of Albendazole Dose on Clearance of Filarial Worms DEC/Albendazole - Lymphatic Filariasis, Wuchereria Bancrofti Infection | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 1000 | 2006-09-09 | 2017-07-02 |
| Effect of Albendazole Dose on Clearance of Filarial Worms Albendazole, Ivermectin - Lymphatic Filariasis | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 1000 | 2006-02-22 | 2017-07-02 |
Elephantiasis, Filarial (6) · Enterobiasis (1) · Malaria (1) · Wounds and Injuries (1) · Yaws (1)
Filariasis (6) · Helminthiasis (6) · Hemic and Lymphatic Diseases (6) · Infections (6) · Lymphatic Diseases (6) · Lymphedema (6) · Mosquito-Borne Diseases (6) · Nematode Infections (6) · Parasitic Diseases (6) · Secernentea Infections (6) · Spirurida Infections (6) · Vector Borne Diseases (6) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Gram-Negative Bacterial Infections (1)
Albendazole (5) · Ivermectin (4) · Diethylcarbamazine (3) · Albumins (1) · Azithromycin (1) · Intravital Microscopy (1)
National Institute of Allergy and Infectious Diseases (NIAID) (3) · Colorado State University (1) · Lihir Medical Centre (1) · University Hospitals Cleveland Medical Center (1)
India (2) · Papua New Guinea (2) · Burkina Faso (1) · Mali (1) · United States (1)
Brian D. Foy, PhD (1) · Peter Siba, PhD (1) · Roch K Dabire, PhD (1) · Thomas B Nutman, M.D. (1)
PMID 26486704, PMID 30403937, PMID 30878222, PMID 32818264, PMID 37262040, PMID 42848323